amantadine has been researched along with Apoplexy in 9 studies
amant: an antiviral compound consisting of an adamantane derivative chemically linked to a water-solube polyanioic matrix; structure in first source
| Excerpt | Relevance | Reference |
|---|---|---|
| "To assess the efficacy and safety of amantadine sulfate in patients with ischemic stroke." | 9.34 | [The use of amantadine sulfate in ischemic stroke]. ( Akhmatkhanova, LK; Kovaleva, EA; Ramazanov, GR; Shevchenko, EV, 2020) |
| "Amantadine and modafinil are neurostimulants that may improve cognitive and functional recovery post-stroke, but the existing study results vary, and no comprehensive review has been published." | 9.05 | Amantadine and Modafinil as Neurostimulants During Post-stroke Care: A Systematic Review. ( Brown, CS; Cote, J; Eldridge, A; Gagnon, DJ; Leclerc, AM; May, T; Nocella, K; Riker, RR; Seder, DB, 2020) |
| "To assess the efficacy and safety of amantadine sulfate in patients with ischemic stroke." | 5.34 | [The use of amantadine sulfate in ischemic stroke]. ( Akhmatkhanova, LK; Kovaleva, EA; Ramazanov, GR; Shevchenko, EV, 2020) |
| "Amantadine and modafinil are neurostimulants that may improve cognitive and functional recovery post-stroke, but the existing study results vary, and no comprehensive review has been published." | 5.05 | Amantadine and Modafinil as Neurostimulants During Post-stroke Care: A Systematic Review. ( Brown, CS; Cote, J; Eldridge, A; Gagnon, DJ; Leclerc, AM; May, T; Nocella, K; Riker, RR; Seder, DB, 2020) |
| "We pooled individual patient data of five single-centre observational studies to determine the effect of amantadine treatment among patients with ischaemic stroke, intracerebral haemorrhage, subarachnoid haemorrhage, community-acquired bacterial meningitis and status epilepticus, admitted between January 2012 and December 2015 and ventilated ≥7 days." | 4.12 | Amantadine treatment is associated with improved consciousness in patients with non-traumatic brain injury. ( Balk, S; Gerner, ST; Giede-Jeppe, A; Huttner, HB; Jäger, J; Kallmünzer, B; Kuramatsu, JB; Madzar, D; Mueller, T; Rühl, L; Schwab, S; Sembill, JA; Sprügel, MI, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 4 (44.44) | 2.80 |
| Authors | Studies |
|---|---|
| Rühl, L | 1 |
| Kuramatsu, JB | 1 |
| Sembill, JA | 1 |
| Kallmünzer, B | 1 |
| Madzar, D | 1 |
| Gerner, ST | 1 |
| Giede-Jeppe, A | 1 |
| Balk, S | 1 |
| Mueller, T | 1 |
| Jäger, J | 1 |
| Schwab, S | 1 |
| Huttner, HB | 1 |
| Sprügel, MI | 1 |
| Gagnon, DJ | 2 |
| Leclerc, AM | 2 |
| Riker, RR | 2 |
| Brown, CS | 2 |
| May, T | 2 |
| Nocella, K | 2 |
| Cote, J | 2 |
| Eldridge, A | 2 |
| Seder, DB | 2 |
| Ramazanov, GR | 1 |
| Kovaleva, EA | 1 |
| Shevchenko, EV | 1 |
| Akhmatkhanova, LK | 1 |
| Wilcox, SK | 1 |
| Garry, A | 1 |
| Johnson, MJ | 1 |
| Krivonos, OV | 1 |
| Amosova, NA | 1 |
| Smolentseva, IG | 1 |
| Barrett, AM | 1 |
| Levy, CE | 1 |
| Gonzalez Rothi, LJ | 1 |
| Kazui, H | 1 |
| Mori, E | 1 |
| Hashimoto, M | 1 |
| Hirono, N | 1 |
| Satou, T | 1 |
| Wada, H | 1 |
| Arai, H | 1 |
| Sasaki, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Amantadine for Neuroenhancement in Acute Patients Study - A Prospective Pilot Proof of Concept Phase IIb Study in Intensive and Intermediate Care Unit Patients[NCT05479032] | Phase 2 | 50 participants (Anticipated) | Interventional | 2022-09-30 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for amantadine and Apoplexy
| Article | Year |
|---|---|
Amantadine and Modafinil as Neurostimulants During Post-stroke Care: A Systematic Review.
Topics: Amantadine; Central Nervous System Stimulants; Dopamine Agents; Humans; Modafinil; Recovery of Funct | 2020 |
2 trials available for amantadine and Apoplexy
| Article | Year |
|---|---|
[The use of amantadine sulfate in ischemic stroke].
Topics: Amantadine; Brain Ischemia; Humans; Ischemic Stroke; Russia; Stroke; Treatment Outcome | 2020 |
Use of the glutamate NMDA receptor antagonist PK-Merz in acute stroke.
Topics: Amantadine; Female; Humans; Male; Middle Aged; Receptors, N-Methyl-D-Aspartate; Stroke | 2010 |
6 other studies available for amantadine and Apoplexy
| Article | Year |
|---|---|
Amantadine treatment is associated with improved consciousness in patients with non-traumatic brain injury.
Topics: Amantadine; Brain Injuries; Brain Ischemia; Consciousness; Delirium; Glasgow Coma Scale; Humans; Sei | 2022 |
Amantadine and Modafinil as Neurostimulants Following Acute Stroke: A Retrospective Study of Intensive Care Unit Patients.
Topics: Adult; Amantadine; Central Nervous System Stimulants; Humans; Intensive Care Units; Modafinil; Retro | 2021 |
Novel use of amantadine: to treat hiccups.
Topics: Aged; Amantadine; Analgesics, Non-Narcotic; Antidepressive Agents; Fatal Outcome; Hiccup; Humans; Ma | 2009 |
Pharmaceuticals for poststroke and brain injury rehabilitation.
Topics: Amantadine; Aphasia, Broca; Brain Injuries; Dopamine Agents; Humans; Methylphenidate; Persistent Veg | 2007 |
Phobia after bilateral thalamic hemorrhage.
Topics: Amantadine; Cerebral Hemorrhage; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Phobic Disor | 2001 |
[The prevention of pneumonia in the elderly by dopamine agonists].
Topics: Aged; Amantadine; Angiotensin-Converting Enzyme Inhibitors; Dopamine Agonists; Humans; Levodopa; Pne | 2001 |